Neoadjuvant Treatment in Breast Cancer; Relationship to HER2 status including HER2 Copy Number using Brightfield Dual in situ Hybridization

被引：0
|
作者：
Neville, Grace [1 ]
O'Connell, Fionnuala [1 ]
Bennett, Michael [1 ]
Feeley, Linda
O'Reilly, Seamus [1 ]
Browne, Tara Jane [1 ]
机构：
[1] Cork Univ Hosp, Cork, Ireland
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
268
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [21] HER2 Copy Number in the Assessment of HER2 Status in Gastric/GOJ Cancers: Does It Matter?
    Kumarasinghe, P.
    de Boer, B.
    Sheng, K.
    Ooi, E.
    Jayasinghe, S.
    Fox, S.
    MODERN PATHOLOGY, 2012, 25 : 166A - 166A
  • [22] HER2 Dual In Situ Hybridization Correlations and Cautions
    Troxell, Megan
    Sibley, Richard K.
    West, Robert B.
    Bean, Gregory R.
    Allison, Kimberly H.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (12) : 1525 - 1534
  • [23] Impact of HER2 Copy Number in IHC HER2 2+/FISH Positive Breast Cancer on Outcome of Adjuvant Trastuzumab Treatment
    Borley, A.
    Mercer, T.
    Morgan, M.
    Barrett-Lee, P.
    Jasani, B.
    JOURNAL OF PATHOLOGY, 2013, 231 : 19 - 19
  • [24] Dual inhibition of HER2 in breast cancer treatment
    Gnant, Michael
    Steger, Guenther G.
    LANCET, 2012, 379 (9816): : 596 - 598
  • [25] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [26] Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies
    Arena, Vincenzo
    Pennacchia, Ilaria
    Monego, Giovanni
    Carbone, Arnaldo
    Capelli, Arnaldo
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : E83 - E84
  • [27] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [28] Impact of neoadjuvant HER2-directed therapy on HER2 status in breast cancer
    Manguso, Nicholas
    Johnson, Jeffrey
    Basho, Reva Kakkar
    McArthur, Heather L.
    Tanaka, Hisashi
    Giuliano, Armando E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer
    Paralta Branco, F.
    Silva, F.
    Andre, S.
    Catarino, A.
    Madureira, R.
    Moreira Pinto, J.
    Godinho, J.
    Simoes, P.
    Freitas, A. C.
    Casa-Nova, M.
    Nave, M.
    Augusto, J.
    Passos-Coelho, J. L.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S94 - S94
  • [30] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    MODERN PATHOLOGY, 2018, 31 : 54 - 54
12345